You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory or relapsed chronic lymphocytic leukemia (CLL) prolymphocytic leukemia (PLL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial

Active, not recruiting
  • Contiguous Stage II Small Lymphocytic Lymphoma
  • +11 more
  • MOR00208
  • +2 more
  • Columbus, Ohio
    The Ohio State University Comprehensive Cancer Center
Feb 24, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial in Columbus (acalabrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Columbus, Ohio
    Research Site
Mar 11, 2022

Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +15 more
  • Anti-CD19/CD20/CD22 CAR T-Cells
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 4, 2022

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +5 more
    • (no location specified)
    Jul 21, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Acalabrutinib (Arm A)
    • Acalabrutinib (Arm B)
    • Bethesda, Maryland
      Research Site
    Jan 3, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Dec 19, 2022

    Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt

    Active, not recruiting
    • Prolymphocytic Leukemia
    • +4 more
    • Columbus, Ohio
    • +1 more
    Apr 29, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Boston, Massachusetts
    • +11 more
    Nov 23, 2022

    Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

    Not yet recruiting
    • Relapsed/Refractory Chronic Lymphocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Jul 13, 2023

    B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Cyclophosphamide injection
    • +2 more
    • Charleston, South Carolina
      Hollings Cancer Center at Medical University of South Carolina
    Jan 18, 2023

    Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

    Active, not recruiting
    • Recurrent Chronic Lymphoid Leukemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Dec 19, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • TQB3909 tablet
    • Zhengzhou, Henan, China
    • +1 more
    Jul 17, 2023

    Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving

    Recruiting
    • Chronic Lymphocytic Leukemia
      • Granada, Spain
      • +4 more
      Nov 8, 2023

      Chronic Lymphocytic Leukemia Trial in Lebanon (BNC105P, Ibrutinib)

      Completed
      • Chronic Lymphocytic Leukemia
      • BNC105P
      • Ibrutinib
      • Lebanon, New Hampshire
        Dartmouth-Hitchcock Medical Center
      Jan 3, 2023

      CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

      Not yet recruiting
      • CLL
      • (no location specified)
      Oct 3, 2023

      Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

      Active, not recruiting
      • Prolymphocytic Leukemia
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 7, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • (no location specified)
      Nov 22, 2023

      Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

      Completed
      • Multiple Myeloma
      • Chronic Lymphocytic Leukemia
      • Myeloma Coach or CLL Coach Mobile App
      • Springboard Beyond Cancer informational website
      • Durham, North Carolina
        Duke University
      Jun 23, 2023

      Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

      Recruiting
      • Non-hodgkin Lymphoma
      • +2 more
      • CC312
      • Tianjin, Tianjin, China
        InstituteHBDH
      Sep 12, 2023

      Chronic Lymphocytic Leukemia (CLL) Trial in Boston (Ibrutinib, Copanlisib, Acalabrutinib)

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      May 13, 2022

      Chronic Lymphocytic Leukemia Trial in Poland, United Kingdom (Ceralasertib, Acalabrutinib)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Kraków, Poland
      • +10 more
      Dec 2, 2022

      Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Questionnaires
      • Fit Bit
      • Houston, Texas
        M D Anderson Cancer Center
      May 18, 2023

      Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)

      Terminated
      Has Results
      • Chronic Lymphocytic Leukemia(CLL)
      • Small Lymphocytic Lymphoma
      • Hackensack, New Jersey
        Hackensack University Medical Center
      Jun 24, 2022